Technical Analysis for RHHVF - Roche Holding AG

Grade Last Price % Change Price Change
grade A 290.65 2.22% 6.3100
RHHVF closed up 2.22 percent on Thursday, October 17, 2019, on 3.97 times normal volume. The price action carved out a bearish shooting star candlestick pattern. That may indicate a downside reversal. Look for price to trade beneath the low of the shooting star for confirmation.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Up Up Up
See historical RHHVF trend table...

Date Alert Name Type % Chg
Shooting Star Candlestick Bearish 0.00%
Lizard Bearish Bearish Day Trade Setup 0.00%
Crossed Above 20 DMA Bullish 0.00%
New 52 Week Closing High Bullish 0.00%
Pocket Pivot Bullish Swing Setup 0.00%
Volume Surge Other 0.00%
Narrow Range Bar Range Contraction 0.00%
Gapped Up Strength 0.00%
Fell Below 20 DMA Bearish 2.22%
Narrow Range Bar Range Contraction 2.22%

Older signals for RHHVF ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Headquartered in Basel, Switzerland, Roche is a leader in research-focused healthcare with combined strengths in pharmaceuticals and diagnostics. Roche is the world's largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and neuroscience. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management. Roche's personalised healthcare strategy aims at providing medicines and diagnostics that enable tangible improvements in the health, quality of life and survival of patients. Founded in 1896, Roche has been making important contributions to global health for more than a century. Twenty-nine medicines developed by Roche are included in the World Health Organization Model Lists of Essential Medicines, among them life-saving antibiotics, antimalarials and chemotherapy.In 2014, the Roche Group employed 88,500 people worldwide, invested 8.9 billion Swiss francs in R&D and posted sales of 47.5 billion Swiss francs. Genentech, in the United States, is a wholly owned member of the Roche Group. Roche is the majority shareholder in Chugai Pharmaceutical, Japan. For more information, please visit roche.com
Health Pharmaceuticals Pharmaceutical Industry Life Sciences Diabetes Pharmaceutical Industry In China Infectious Diseases Chemotherapy Neuroscience Antibiotics In Vitro Diagnostics Genentech Hoffmann La Roche Diabetes Management Roche World Health Organization Personalised Healthcare Strategy Research Focused Healthcare Tissue Based Cancer
Is RHHVF a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 300.4055
52 Week Low 230.72
Average Volume 7,449
200-Day Moving Average 270.5371
50-Day Moving Average 280.2195
20-Day Moving Average 287.2468
10-Day Moving Average 288.278
Average True Range 3.5532
ADX 30.63
+DI 45.4131
-DI 30.1097
Chandelier Exit (Long, 3 ATRs ) 281.1004
Chandelier Exit (Short, 3 ATRs ) 288.7096
Upper Bollinger Band 292.4904
Lower Bollinger Band 282.0032
Percent B (%b) 0.82
BandWidth 3.650937
MACD Line 2.4232
MACD Signal Line 2.7327
MACD Histogram -0.3095
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 292.4950
Resistance 3 (R3) 292.6333 292.1567 292.1875
Resistance 2 (R2) 292.1567 291.6868 292.0875 292.0849
Resistance 1 (R1) 291.4033 291.3965 291.7800 291.2650 291.9825
Pivot Point 290.9267 290.9267 291.1150 290.8575 290.9267
Support 1 (S1) 290.1733 290.4568 290.5500 290.0350 289.3175
Support 2 (S2) 289.6967 290.1665 289.6275 289.2151
Support 3 (S3) 288.9433 289.6967 289.1125
Support 4 (S4) 288.8050